title: Zygomycete infection following voriconazole prophylaxis.
authors.affiliation: Department of Paediatric Infectious Diseases, VU University Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands. g.vanwell@vumc.nl
authors.forename: Gijs T J
authors.initials: GT
authors.lastname: van Well
authors.forename: Iris
authors.initials: I
authors.lastname: van Groeningen
authors.forename: Yvette J
authors.initials: YJ
authors.lastname: Debets-Ossenkopp
authors.forename: A Marceline
authors.initials: AM
authors.lastname: van Furth
authors.forename: C Michel
authors.initials: CM
authors.lastname: Zwaan
mesh_terms: D000293:Adolescent; D000935:Antifungal Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D025141:Drug Resistance, Fungal; D017809:Fatal Outcome; D006801:Humans; D016867:Immunocompromised Host; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000188:drug therapy; D008297:Male; D008826:Microbial Sensitivity Tests; D011743:Pyrimidines / Q000627:therapeutic use*; D012233:Rhizopus / Q000187:drug effects / Q000254:growth & development; D014230:Triazoles / Q000627:therapeutic use*; D065819:Voriconazole; D020096:Zygomycosis / Q000188:drug therapy / Q000517:prevention & control*
chemical_list: D000935:Antifungal Agents; D000970:Antineoplastic Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole